Jolanta Nowak

1.8k total citations · 1 hit paper
47 papers, 1.3k citations indexed

About

Jolanta Nowak is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jolanta Nowak has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Jolanta Nowak's work include Pulmonary Hypertension Research and Treatments (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Heart Failure Treatment and Management (6 papers). Jolanta Nowak is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Heart Failure Treatment and Management (6 papers). Jolanta Nowak collaborates with scholars based in Poland, Germany and United Kingdom. Jolanta Nowak's co-authors include Piotr Rozentryt, Lech Poloński, Piotr Ponikowski, Ewa A. Jankowska, Beata Ponikowska, Oliver Hartmann, Ludmiła Borodulin- Nadzieja, Stephan von Haehling, John J.V. McMurray and S. D. Anker and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and Nutrients.

In The Last Decade

Jolanta Nowak

44 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Iron deficiency: an ominous sign in patients with systolic chronic heart failure

2010 481 citations Ewa A. Jankowska, Piotr Rozentryt et al. European Heart Journal profile →

Peers

Countries citing papers authored by Jolanta Nowak

Since Specialization

Citations

This map shows the geographic impact of Jolanta Nowak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Nowak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Nowak more than expected).

Fields of papers citing papers by Jolanta Nowak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta Nowak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Nowak. The network helps show where Jolanta Nowak may publish in the future.

Co-authorship network of co-authors of Jolanta Nowak

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Nowak. A scholar is included among the top collaborators of Jolanta Nowak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Nowak. Jolanta Nowak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Long-term prognostic scores may underestimate the risk of death in patients with heart failure with reduced ejection fraction in whom red cells distribution width is elevated	Polskie Archiwum Medycyny Wewnętrznej	Jolanta Nowak, Jacek Niedziela et al.	0
2	Prognostic Value of Spot Urinary Creatinine Concentration and Its Relationship with Body Composition Parameters in HF Patients	Biomedicines	Jacek Niedziela, Jolanta Nowak et al.	1
3	Sacubitril/Valsartan for Cardioprotection in Breast Cancer (MAINSTREAM): Design and Rationale of the Randomized Trial	ESC Heart Failure	Mateusz Tajstra, Tomasz A. Rutkowski et al.	11
4	Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure	Journal of Cardiovascular Development and Disease	Bartosz Hudzik, Jolanta Nowak et al.	5
5	Impact of cellular myocardial infiltration on clinical outcome in non-ischaemic heart failure	Journal of Clinical Pathology	Jolanta Nowak, Krzysztof Kaczmarek et al.	1
6	Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry	Atherosclerosis	Krzysztof Dyrbuś, Mariusz Gąsior et al.	17
7	Iron deficiency contributes to resistance to endogenous erythropoietin in anaemic heart failure patients	European Journal of Heart Failure	Michał Tkaczyszyn, Josep Comín‐Colet et al.	6
8	Improved prognosis in patients with recurrent hospitalizations for heart failure after day-care management	Kardiologia Polska	Mariusz Gąsior, Jacek Niedziela et al.	1
9	Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19,287 patients	Pharmacological Research	Krzysztof Dyrbuś, Mariusz Gąsior et al.	27
10	Mean platelet volume is associated with serum 25-hydroxyvitamin D concentrations in patients with stable coronary artery disease	Heart and Vessels	Ilona Korzonek-Szlacheta, Bartosz Hudzik et al.	18
11	Epidemiology of out-of-hospital cardiac arrest in the Bielsko-Biala district: a 12-month analysis	Kardiologia Polska	Jolanta Nowak, Łukasz J. Krzych et al.	22
12	Clinical and laboratory determinants of 25-hydroxyvitamin D deficiency during pharmacotherapeutic escalation in heart failure patients	Polish Journal of Cardio-Thoracic Surgery	Krzysztof Myrda, Piotr Rozentryt et al.	1
13	Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure	Journal of Cardiac Failure	Ewa A. Jankowska, Piotr Rozentryt et al.	219
14	The effects of a high‐caloric protein‐rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double‐blind pilot study	Journal of Cachexia Sarcopenia and Muscle	Piotr Rozentryt, Stephan von Haehling et al.	138
15	Therapeutic Window for Calcium-Channel Blockers in the Management of Dilated Cardiomyopathy: A Prospective, Two-Centre Study on Non-Advanced Disease	Cardiology	Romuald Wojnicz, Jolanta Nowak et al.	4
16	Iron deficiency: an ominous sign in patients with systolic chronic heart failure breakdown →	European Heart Journal	Ewa A. Jankowska, Piotr Rozentryt et al.	481
17	Left ventricular dysfunction in patients with interstitial lung diseases referred for lung transplantation.	PubMed	Dariusz Jastrzębski, Jolanta Nowak et al.	3
18	Dzielimy się doświadczeniem The assessment of left and right ventricular function in patients with severe pulmonary diseases		Jolanta Nowak, Tomasz Kukulski et al.	1
19	Usefulness of Atorvastatin in Patients With Heart Failure Due to Inflammatory Dilated Cardiomyopathy and Elevated Cholesterol Levels	The American Journal of Cardiology	Romuald Wojnicz, Krzysztof Wilczek et al.	85
20	Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results of the randomized trial	American Heart Journal	Romuald Wojnicz, Jolanta Nowak et al.	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact